Abstract

Lamin A/C (LMNA) encodes for two nuclear intermediate filament proteins. Mutations in LMNA cause a highly heterogeneous group of diseases predominantly leading to muscular or cardiac disease, lipodystrophy syndromes, peripheral neuropathy, and accelerated aging disorders. Cardiac involvement includes progressive arrhythmias (brady/tachyarrhythmias, sudden cardiac death). Furthermore, cardiomyocyte damage often progresses into dilated cardiomyopathy (DCM), rarely described in the pediatric age group. Neuromuscular manifestations are even rarer in children. We report on six pediatric patients with LMNA mutations: patient 1 was operated on for aortic coarctation, non-compact left ventricle, atrial fibrillation (AF) preceding the diagnosis of DCM; patient 2 was operated on for ventricular septal defect (VSD), developed after years malignant arrhythmias preceding the progression to DCM (left ventricular non-compaction with LV dysfunction); patient 3 had ectopic atrial tachycardia as first manifestation of a DCM; patients 4 and 5 had no major arrhythmic events but only dilated ascending aorta, mildly dilated LV with mild hypertrabeculation of the lateral wall and a normally functioning but dilated left ventricle, respectively; patient 6 showed aortic coarctation, supraventricular tachycardia. Paroxysmal AF occurred in patients 1, 2, and 3 (50% of cases). Our series highlight the coexistence of congenital heart defects (CHDs) and aortic involvement with laminopathies in four of our patients: consisting of aortic coarctation (two patients), aortic root dilatation (one patient), and VSD (one patient). Aortic changes in laminopathies have been reported only once in an adult patient. This is the first report in the pediatric setting, and no associations with CHD have been previously described.

Highlights

  • Lamin A/C (LMNA) (OMIM ∗150330) is located on chromosome 1q21.22 [1] and includes 12 exons

  • To the best of our knowledge, this is the first described experience of pediatric cardiogenetic screening with an next-generation sequencing (NGS) panel containing LMNA in a cohort of children affected by heterogeneous cardiac phenotypes including CMP, congenital heart defects (CHDs), and arrhythmias

  • Our experience reports the importance of investigating in childhood cohorts laminopathies as a possible cause of progressive left ventricle (LV) dysfunction/dilated cardiomyopathy (DCM) or bradyarryhthmias/tachyarrhythmias even in the absence of clear neuromuscular involvement and infrequent increase in Creatine kinase (CK)

Read more

Summary

Introduction

LMNA (OMIM ∗150330) is located on chromosome 1q21.22 [1] and includes 12 exons. Five A-type lamins (A, AD10, AD150, C, and C2) are encoded and are produced by alternative splicing. Lamins A and C are the two major isoforms, and the latter has the highest expressed transcript [2, 3]. Nuclear lamina is the term applied to the ubiquitous nuclear intermediate filament proteins. Nuclear stability is offered through the binding process to a major number of nuclear protein complexes. They help connect the nucleus to the cytoskeleton and contribute to genome stability, differentiation, modulate chromatin organization, gene regulation and expression, and tissue-specific functions [4, 5]

Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call